MammoScreen™ by Therapixel at RSNA 2020
The 106th Annual Meeting of Radiology Society of North America (RSNA) is right around the corner! RSNA 2020 will be a purely online event, to be held from November 29–December 5, 2020.
We are proud once again be a part of this major radiology conference. Be sure to navigate to our online virtual booth where we will be demonstrating MammoScreen™, our FDA-cleared award-winning AI for breast cancer screening.
At our booth, you have an opportunity to:
● discover your peer sharing his experience on using MammoScreen™ in his practice
● have a quick look at MammoScreen™ in action
● virtually meet us to discuss what our decision-making aid for breast cancer screening can bring to your practice.
About MammoScreen
MammoScreen™ is an AI-based proficiency tool that helps radiologists interpret mammograms more accurately and faster. Working alongside radiologists, its uniquely actionable MammoScreen Score™ allows radiologists — at a glance — to quickly confirm what they suspect while providing the accuracy to detect what may have been missed. This allows radiologists to concentrate their energies on the questionable cases that require further scrutiny.
Practice-friendly. Subscription-based and vendor-neutral, MammoScreen easily fits into existing infrastructure providing non-intrusive zero-click workflow.
Award-winning. Winner of the DREAM Digital Mammography Challenge, the largest competition ever organized in AI for breast imaging.
FDA approved. MammoScreen is FDA-cleared and available for sale in the US.
About RSNA
RSNA 2020, Human Insight/Visionary Medicine, is a can’t-miss radiology event where industry professionals can discover the latest innovations in their field and learn about the newest medical imaging advances.
MammoScreen team will be pleased to virtually meet you at the RSNA and answer your technology-related questions!
Hope to see you there!